{"pmid":32435648,"pmcid":"PMC7218121","title":"Coronavirus Disease 2019 Emergency and Cancer in the South of Italy: What's New for the Oncologist?","text":["Coronavirus Disease 2019 Emergency and Cancer in the South of Italy: What's New for the Oncologist?","Front Med (Lausanne)","Ingenito, Concetta","Buonerba, Luciana","Ferrara, Claudia","Busto, Giuseppina","Libroia, Annamaria","Ragone, Gianluca","Leo, Emilio","Savastano, Beatrice","Ioio, Concetta Dello","De Falco, Ferdinando","Iaccarino, Simona","Tarantino, Luciano","Polverino, Mario","Di Lorenzo, Giuseppe","32435648"],"journal":"Front Med (Lausanne)","authors":["Ingenito, Concetta","Buonerba, Luciana","Ferrara, Claudia","Busto, Giuseppina","Libroia, Annamaria","Ragone, Gianluca","Leo, Emilio","Savastano, Beatrice","Ioio, Concetta Dello","De Falco, Ferdinando","Iaccarino, Simona","Tarantino, Luciano","Polverino, Mario","Di Lorenzo, Giuseppe"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32435648","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.3389/fmed.2020.00189","keywords":["cancer","coronavirus disease","management","patients","treatment"],"topics":["Prevention"],"weight":1,"_version_":1667521393658429442,"score":9.490897,"similar":[{"pmid":32212779,"title":"Cancer Care Delivery Challenges Amidst Coronavirus Disease - 19 (COVID-19) Outbreak: Specific Precautions for Cancer Patients and Cancer Care Providers to Prevent Spread.","text":["Cancer Care Delivery Challenges Amidst Coronavirus Disease - 19 (COVID-19) Outbreak: Specific Precautions for Cancer Patients and Cancer Care Providers to Prevent Spread.","Coronavirus outbreak has affected thousands of people in at least 186 countries which has affected the cancer care delivery system apart from affecting the overall health system. Cancer patients are more susceptible to coronavirus infection than individuals without cancer as they are in an immunosuppressive state because of the malignancy and anticancer treatment. Oncologists should be more attentive to detect coronavirus infection early, as any type of advanced cancer is at much higher risk for unfavorable outcomes. Oncology communities must ensure that cancer patients should spend more time at home and less time out in the community. Oncologists and other health care professionals involved in cancer care have a critical opportunity to communicate to their patients to pass on right information regarding practice modifications in view of COVID-19 outbreaks. Countries must isolate, test, treat and trace to control the coronavirus pandemic. There is a paucity of information on novel coronavirus infection and its impact on cancer patients and cancer care providers. To date, there is no scientific guideline regarding management of cancer patients in a background of coronavirus outbreak.<br />.","Asian Pac J Cancer Prev","Shankar, Abhishek","Saini, Deepak","Roy, Shubham","Mosavi Jarrahi, Alireza","Chakraborty, Abhijit","Bharti, Sachidanand Jee","Taghizadeh-Hesary, Farzad","32212779"],"abstract":["Coronavirus outbreak has affected thousands of people in at least 186 countries which has affected the cancer care delivery system apart from affecting the overall health system. Cancer patients are more susceptible to coronavirus infection than individuals without cancer as they are in an immunosuppressive state because of the malignancy and anticancer treatment. Oncologists should be more attentive to detect coronavirus infection early, as any type of advanced cancer is at much higher risk for unfavorable outcomes. Oncology communities must ensure that cancer patients should spend more time at home and less time out in the community. Oncologists and other health care professionals involved in cancer care have a critical opportunity to communicate to their patients to pass on right information regarding practice modifications in view of COVID-19 outbreaks. Countries must isolate, test, treat and trace to control the coronavirus pandemic. There is a paucity of information on novel coronavirus infection and its impact on cancer patients and cancer care providers. To date, there is no scientific guideline regarding management of cancer patients in a background of coronavirus outbreak.<br />."],"journal":"Asian Pac J Cancer Prev","authors":["Shankar, Abhishek","Saini, Deepak","Roy, Shubham","Mosavi Jarrahi, Alireza","Chakraborty, Abhijit","Bharti, Sachidanand Jee","Taghizadeh-Hesary, Farzad"],"date":"2020-03-28T11:00:00Z","year":2020,"_id":"32212779","source":"PubMed","week":"202013|Mar 23 - Mar 29","doi":"10.31557/APJCP.2020.21.3.569","keywords":["covid-19","cancer","healthcare providers","patients"],"topics":["Prevention"],"weight":1,"_version_":1666138492336340992,"score":100.03223},{"pmid":32467810,"pmcid":"PMC7250517","title":"Coronavirus Disease 2019 (COVID-19) in Cancer Patients.","text":["Coronavirus Disease 2019 (COVID-19) in Cancer Patients.","The Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become the most talked-about clinical entity in early 2020. As an infection that spreads easily and has a significant mortality rate, it has caused global panic rarely seen before. Many of the measures taken by governments worldwide will have long-lasting impacts on the wellbeing of the population at large. It has been widely reported that the most vulnerable patients have been most negatively affected by SARS-CoV-2 (COVID-19). In this study, we have tried to search the currently available data on the outcomes of infected cancer patients. Most of the data points to the very challenging nature of treating such patients. Their overall outcomes seem to be worse than in the general population, and it may be difficult to differentiate which potential complications are a result of the primary oncologic disease versus the infection. Management presents its own set of challenges, including but not limited to, deciding whether postponing cancer treatment until the infection resolves is going to benefit the patient and how to organize all aspects of patient care when social contact is as limited as it is for patients newly diagnosed with COVID-19. We believe that as more data becomes available, it is going to be necessary to publish detailed guidelines on how to approach this unique clinical challenge.","Cureus","Cancarevic, Ivan","Tathineni, Praveena","Malik, Bilal Haider","32467810"],"abstract":["The Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become the most talked-about clinical entity in early 2020. As an infection that spreads easily and has a significant mortality rate, it has caused global panic rarely seen before. Many of the measures taken by governments worldwide will have long-lasting impacts on the wellbeing of the population at large. It has been widely reported that the most vulnerable patients have been most negatively affected by SARS-CoV-2 (COVID-19). In this study, we have tried to search the currently available data on the outcomes of infected cancer patients. Most of the data points to the very challenging nature of treating such patients. Their overall outcomes seem to be worse than in the general population, and it may be difficult to differentiate which potential complications are a result of the primary oncologic disease versus the infection. Management presents its own set of challenges, including but not limited to, deciding whether postponing cancer treatment until the infection resolves is going to benefit the patient and how to organize all aspects of patient care when social contact is as limited as it is for patients newly diagnosed with COVID-19. We believe that as more data becomes available, it is going to be necessary to publish detailed guidelines on how to approach this unique clinical challenge."],"journal":"Cureus","authors":["Cancarevic, Ivan","Tathineni, Praveena","Malik, Bilal Haider"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32467810","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.7759/cureus.7835","keywords":["2019 novel coronavirus","cancer","cancer patients","coronavirus disease","coronavirus pandemic","lung cancer","novel coronavirus","sars-cov-2","severe acute respiratory syndrome coronavirus 2","wuhan coronavirus"],"topics":["Prevention"],"weight":1,"_version_":1668167110007717888,"score":73.674805},{"pmid":32458596,"title":"Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists.","text":["Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists.","The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 has rapidly spread globally. Cancer patients are at a higher risk of being infected with the coronavirus and are more likely to develop severe complications, as compared to the general population. The increasing spread of COVID-19 presents challenges for the clinical care of patients with gynecological malignancies. Concerted efforts should be put into managing gynecological malignancies in an orderly manner by strictly implementing the measures that are specifically developed for controlling the spread of COVID-19. We have drafted Recommendations on Management of Gynecological Malignancies during the COVID-19 Pandemic based on our experience on controlling COVID-19 pandemic in China. We recommend that patients with gynecological malignancies should be managed in hierarchical and individualized manners in combination with local conditions related to COVID-19. Medical care decision should be balanced between controlling COVID-19 pandemic spread and timely diagnosis and treatment for gynecologic oncology patients.","J Gynecol Oncol","Wang, Yingmei","Zhang, Shiqian","Wei, Lihui","Lin, Zhongqiu","Wang, Xinyu","Wang, Jianliu","Hua, Keqin","Cui, Manhua","Wang, Jiandong","Wang, Shixuan","Di, Wen","Wang, Yudong","An, Ruifang","Xi, Mingrong","Guo, Ruixia","Zhou, Qi","Xie, Xing","Xue, Fengxia","32458596"],"abstract":["The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 has rapidly spread globally. Cancer patients are at a higher risk of being infected with the coronavirus and are more likely to develop severe complications, as compared to the general population. The increasing spread of COVID-19 presents challenges for the clinical care of patients with gynecological malignancies. Concerted efforts should be put into managing gynecological malignancies in an orderly manner by strictly implementing the measures that are specifically developed for controlling the spread of COVID-19. We have drafted Recommendations on Management of Gynecological Malignancies during the COVID-19 Pandemic based on our experience on controlling COVID-19 pandemic in China. We recommend that patients with gynecological malignancies should be managed in hierarchical and individualized manners in combination with local conditions related to COVID-19. Medical care decision should be balanced between controlling COVID-19 pandemic spread and timely diagnosis and treatment for gynecologic oncology patients."],"journal":"J Gynecol Oncol","authors":["Wang, Yingmei","Zhang, Shiqian","Wei, Lihui","Lin, Zhongqiu","Wang, Xinyu","Wang, Jianliu","Hua, Keqin","Cui, Manhua","Wang, Jiandong","Wang, Shixuan","Di, Wen","Wang, Yudong","An, Ruifang","Xi, Mingrong","Guo, Ruixia","Zhou, Qi","Xie, Xing","Xue, Fengxia"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32458596","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.3802/jgo.2020.31.e68","keywords":["covid-19","gynecological malignancies","management","pandemic","recommendations"],"locations":["China","Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1668141322609885184,"score":68.11255},{"pmid":32391283,"pmcid":"PMC7190805","title":"COVID-19 Infection in Cancer Patients: How Can Oncologists Deal With These Patients?","text":["COVID-19 Infection in Cancer Patients: How Can Oncologists Deal With These Patients?","Front Oncol","Brunetti, Oronzo","Derakhshani, Afshin","Baradaran, Behzad","Galvano, Antonio","Russo, Antonio","Silvestris, Nicola","32391283"],"journal":"Front Oncol","authors":["Brunetti, Oronzo","Derakhshani, Afshin","Baradaran, Behzad","Galvano, Antonio","Russo, Antonio","Silvestris, Nicola"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32391283","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.3389/fonc.2020.00734","keywords":["covid-19","cancer","prognosis","screening","therapy"],"topics":["Prevention"],"weight":1,"_version_":1666528580115365888,"score":67.20394},{"pmid":32352202,"title":"Clinical and Epidemiological Characteristics of 1,420 European Patients with mild-to-moderate Coronavirus Disease 2019.","text":["Clinical and Epidemiological Characteristics of 1,420 European Patients with mild-to-moderate Coronavirus Disease 2019.","BACKGROUND: The clinical presentation of European patients with mild-to-moderate Covid-19 infection is still unknown. OBJECTIVE: To study the clinical presentation of Covid-19 in Europe. METHODS: Patients with positive diagnosis of Covid-19 were recruited from 18 European hospitals. Epidemiological and clinical data were obtained through a standardized questionnaire. Bayesian analysis was used for analyzing the relationship between outcomes. RESULTS: 1,420 patients completed the study (962 females, 30.7% of health care workers). The mean age of patients was 39.17+/-12.09 years. The most common symptoms were headache (70.3%), loss of smell (70.2%), nasal obstruction (67.8%), cough (63.2%), asthenia (63.3%), myalgia (62.5%), rhinorrhea (60.1%), gustatory dysfunction (54.2%) and sore throat (52.9%). Fever was reported by on 45.4%. The mean duration of Covid-19 symptoms of mild-to-moderate cured patients was 11.5+/-5.7 days. The prevalence of symptoms significantly varied according to age and sex. Young patients more frequently had ear, nose, and throat complaints, whereas elderly individuals often presented fever, fatigue and loss of appetite. Loss of smell, headache, nasal obstruction and fatigue were more prevalent in female patients. The loss of smell was a key symptom of mild-to-moderate Covid19 patients and was not associated with nasal obstruction and rhinorrhea. Loss of smell persisted at least 7 days after the disease in 37.5% of cured patients. CONCLUSION: The clinical presentation of mild-to-moderate Covid-19 substantially varies according to the age and the sex characteristics of patients. Olfactory dysfunction seems to be an important underestimated symptom of mild-to-moderate Covid-19 that needs to be recognized as such by the WHO.","J Intern Med","Lechien, Jerome R","Chiesa-Estomba, Carlos M","Place, Sammy","Van Laethem, Yves","Cabaraux, Pierre","Mat, Quentin","Huet, Kathy","Plzak, Jan","Horoi, Mihaela","Hans, Stephane","Barillari, Maria Rosaria","Cammaroto, Giovanni","Fakhry, Nicolas","Martiny, Delphine","Ayad, Tareck","Jouffe, Lionel","Hopkins, Claire","Saussez, Sven","32352202"],"abstract":["BACKGROUND: The clinical presentation of European patients with mild-to-moderate Covid-19 infection is still unknown. OBJECTIVE: To study the clinical presentation of Covid-19 in Europe. METHODS: Patients with positive diagnosis of Covid-19 were recruited from 18 European hospitals. Epidemiological and clinical data were obtained through a standardized questionnaire. Bayesian analysis was used for analyzing the relationship between outcomes. RESULTS: 1,420 patients completed the study (962 females, 30.7% of health care workers). The mean age of patients was 39.17+/-12.09 years. The most common symptoms were headache (70.3%), loss of smell (70.2%), nasal obstruction (67.8%), cough (63.2%), asthenia (63.3%), myalgia (62.5%), rhinorrhea (60.1%), gustatory dysfunction (54.2%) and sore throat (52.9%). Fever was reported by on 45.4%. The mean duration of Covid-19 symptoms of mild-to-moderate cured patients was 11.5+/-5.7 days. The prevalence of symptoms significantly varied according to age and sex. Young patients more frequently had ear, nose, and throat complaints, whereas elderly individuals often presented fever, fatigue and loss of appetite. Loss of smell, headache, nasal obstruction and fatigue were more prevalent in female patients. The loss of smell was a key symptom of mild-to-moderate Covid19 patients and was not associated with nasal obstruction and rhinorrhea. Loss of smell persisted at least 7 days after the disease in 37.5% of cured patients. CONCLUSION: The clinical presentation of mild-to-moderate Covid-19 substantially varies according to the age and the sex characteristics of patients. Olfactory dysfunction seems to be an important underestimated symptom of mild-to-moderate Covid-19 that needs to be recognized as such by the WHO."],"journal":"J Intern Med","authors":["Lechien, Jerome R","Chiesa-Estomba, Carlos M","Place, Sammy","Van Laethem, Yves","Cabaraux, Pierre","Mat, Quentin","Huet, Kathy","Plzak, Jan","Horoi, Mihaela","Hans, Stephane","Barillari, Maria Rosaria","Cammaroto, Giovanni","Fakhry, Nicolas","Martiny, Delphine","Ayad, Tareck","Jouffe, Lionel","Hopkins, Claire","Saussez, Sven"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32352202","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/joim.13089","keywords":["europe","clinical","coronavirus","covid-19","epidemiological","medicine","patients","symptoms"],"locations":["myalgia"],"topics":["Diagnosis"],"weight":1,"_version_":1666138495700172800,"score":65.58566}]}